SCHEMBL12200466

SCHEMBL12200466

Cc1cc(C)c(-c2nc(-c3c(C)cc(C)cc3C)nc(-c3ccc4c5c3ccc3ccc6cccc-4c6c35)n2)c(C)c1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
TSHR P16473 3/20 0.37
HSD17B10 Q99714 3/20 0.37
HPGD P15428 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
CYP3A4 P08684 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CRHR1 P34998 4/20 0.34
CYP1A2 P05177 3/20 0.33
CYP2A6 P11509 2/20 0.33
MAPK1 P28482 2/20 0.32
TP53 P04637 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
HIF1A Q16665 1/20 0.32
ATM Q13315 1/20 0.31
PDK2 Q15119 1/20 0.31
AR P10275 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12200468 0.90 ALDH1A1 (0.47) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL12200455 0.90 ALDH1A1 (0.40) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL12200502 0.87 ALDH1A1 (0.36) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL12200467 0.86 CYP1A2 (0.39) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL12200462 0.82 KDM4E (0.41) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL12200446 0.80 CYP1A2 (0.36) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL12200457 0.79 ALDH1A1 (0.52) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL12200497 0.79 ALDH1A1 (0.46) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL12200503 0.78 KDM4E (0.35) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL12200509 0.76 ALDH1A1 (0.32) ALDH1A1TSHRHSD17B10HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160197289-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-07-07 US disclosed
US-20160197289-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-07-07 US disclosed
US-8765270-B2 Triazine compound and organic light emitting device using the same CANON KABUSHIKI KAISHA (JP) 2014-07-01 US disclosed
US-8765270-B2 Triazine compound and organic light emitting device using the same CANON KABUSHIKI KAISHA (JP) 2014-07-01 US disclosed
US-20110240983-A1 TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2011-10-06 US disclosed
US-20110240983-A1 TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2011-10-06 US disclosed
WO-2010067894-A1 TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110240983-A1 TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME TERT, CYP1A1, NR2E3 ALDH1A1 44/4885TSHR 952/4885HSD17B10 1689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.